๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Liver transplantation for hepatitis C

โœ Scribed by Marubashi, Shigeru ;Dono, Keizo ;Miyamoto, Atsushi ;Takeda, Yutaka ;Nagano, Hiroaki ;Umeshita, Koji ;Monden, Morito


Publisher
Springer
Year
2006
Tongue
English
Weight
199 KB
Volume
13
Category
Article
ISSN
0944-1166

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Liver transplantation for hepatitis C vi
โœ Nancy L. Ascher; John R. Lake; Jean Emond; John Roberts ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 416 KB ๐Ÿ‘ 1 views

Since the introduction of techniques to reliably identify antibody to the hepatitis C virus and quantitation of hepatitis C virus, there has been an increasing interest in the behavior of chronic hepatitis C infection with liver transplantation. Ninety-seven patients with chronic active hepatitis C

Histological and clinical outcome after
โœ M C Shuhart; M P Bronner; D R Gretch; L V Thomassen; C F Wartelle; H Tateyama; S ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 189 KB ๐Ÿ‘ 1 views

Hepatitis frequently recurs after liver transplantation for early recurrence is associated with a higher risk of disease progression. (HEPATOLOGY 1997;26:1646-1652.) hepatitis C. However, the histological progression of disease, predictors of recurrence and disease severity, and patient survival rem

Liver transplantation for hepatitis C: T
โœ Adrian M. Di Bisceglie ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 342 KB

Cirrhosis caused by chronic hepatitis is currently one of the leading indications for liver transplantation among adults in the United States and western Europe.' Chronic infection with hepatitis C virus (HCV) is a relatively common condition affecting approximately 1.4% of the general population in

Predictors of patient and graft survival
โœ Michael Charlton; Eric Seaberg; Russell Wiesner; James Everhart; Rowen Zetterman ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 129 KB ๐Ÿ‘ 1 views

End-stage liver disease secondary to hepatitis C virus (HCV) infection is the leading indication for liver transplantation in the United States. Recurrence of HCV infection is nearly universal. We studied the patients enrolled in the National Institute of Diabetes and Digestive and Kidney Diseases L